The MnSOD Ala16Val SNP: Relevance to human diseases and interaction with environmental factors

Free Radical Research

Volumn 47, Issue 10, 2013, Pages 781-792

  Bresciani, Guilherme ^a   Cruz, I B M ^a   De Paz, J A ^b   Cuevas, M J ^b   Gonzalez Gallego J ^b  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b UNIVERSITY OF LEÓN   (Spain)

Author keywords

Antioxidant enzymes; Health conditions; Nature and nurture; Oxidative stress

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; MANGANESE SUPEROXIDE DISMUTASE; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; VALINE;

ALCOHOL INTOXICATION; ANGINA PECTORIS; BREAST CANCER; CARDIOGENIC SHOCK; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASES; ENVIRONMENTAL FACTOR; ENZYME LOCALIZATION; EXERCISE; GENETIC VARIABILITY; HEMOCHROMATOSIS; HEPATITIS C; HUMAN; INFLAMMATION; KIDNEY DISEASE; LIPID PEROXIDATION; LIVER CELL CARCINOMA; MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION; OXIDATIVE STRESS; PANCREAS ADENOCARCINOMA; PHYSICAL ACTIVITY; POLYNEUROPATHY; PROTEIN CARBONYLATION; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; ANTIOXIDANTS; ENVIRONMENTAL EXPOSURE; HUMANS; OXIDATIVE STRESS; POLYMORPHISM, SINGLE NUCLEOTIDE; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 84884238246     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2013.836275     Document Type: Review

References (112)

1. Powers SK, Duarte J, Kavazis AN, Talbert EE. Reactive oxygen species are signalling molecules for skeletal muscle adaptation. Exp Physiol 2010; 95: 1-9.
2. Pourova J, Kottova M, Voprsalova M, Pour M. Reactive oxygen and nitrogen species in normal physiological processes. Acta Physiol 2010; 198: 15-35.
3. Ray PD, Huang BW, Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 2012; 24: 981-990.
4. Gonz á lez-Gallego J, Garc í a-Mediavilla MV, S á nchez- Campos S, Tu ñ ón MJ. Fruit polyphenols, immunity and inflammation. Br J Nutr 2010; 104: S15-S27.
5. Crespo I, Garc í a-Mediavilla MV, Almar M, Gonz á lez P, Tu ñ ón MJ, Sánchez-Campos S, González-Gallego J. Diff erential eff ects of dietary flavonoids on reactive oxygen and nitrogen species generation and changes in antioxidant enzyme expression induced by proinflammatory cytokines in Chang Liver cells. Food Chem Toxicol 2008; 46: 1555-1569.
6. Finaud J, Lac G, Filaire E. Oxidative stress: relationship with exercise and training. Sports Med 2006; 36: 327-358.
7. Edeas M. Strategies to target mitochondria and oxidative stress by antioxidants: key points and perspectives. Pharm Res 2011; 28: 2771-2779.
8. Da Costa LA, Badawi A, El-Sohemy A. Nutrigenetics and modulation of oxidative stress. Ann Nutr Metab 2012; 60: 27-36.
9. Valdivia A, P é rez-Alvarez S, Aroca-Aguilar JD, Ikuta I, Jord á n J. Superoxide dismutases: a physiopharmacological update. J Physiol Biochem 2009; 65: 195-208.
10. Miller AF. Superoxide dismutases: ancient enzymes and new insights. FEBS Lett 2012; 586: 585-595.
11. Miao L, St Clair DK. Regulation of superoxide dismutase genes: implications in disease. Free Radic Biol Med 2009; 47: 344-356.
12. Miriyala S, Spasojevic I, Tovmasyan A, Salvemini D, Vujaskovic Z, St Clair D, Batinic-Haberle I. Manganese superoxide dismutase, MnSOD and its mimics. Biochim Biophys Acta 2012; 1822: 794-814.
13. Parge HE, Hallewell RA, Tainer JA. Atomic structures of wild-type and thermostable mutant recombinant human Cu,Zn superoxide dismutase. Proc Natl Acad Sci USA 1992; 89: 6109-6113.
14. Bag A, Bag N. Target sequence polymorphism of human manganese superoxide dismutase gene and its association with cancer risk: a review. Cancer Epidemiol Biomarkers Prev 2008; 17: 3298-3305.
15. Wang V, Chen SY, Chuang TC, Shan DE, Soong BW, Kao MC. Val-9Ala and Ile - 58 Thr polymorphism of MnSOD in Parkinson' s disease. Clin Biochem 2010; 43: 979-982.
16. Wang S, Wang F, Shi X, Dai J, Peng Y, Guo X, et al. Association between manganese superoxide dismutase (MnSOD) Val-9Ala polymorphism and cancer risk - A metaanalysis. Eur J Cancer 2009; 45: 2874-2881.
17. Crawford A, Fassett RG, Geraghty DP, Kunde DA, Ball MJ, Robertson IK, Coombes JS. Relationships between single nucleotide polymorphisms of antioxidant enzymes and disease. Gene 2012; 501: 89-103.
18. Forsberg L, de Faire U, Morgenstern R. Oxidative stress, human genetic variation, and disease. Arch Biochem Biophys 2001; 389: 84-93.
19. Wang DG, Fan JB, Siao CJ, Berno A, Young P, Sapolsky R, et al. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science 1998; 280: 1077-1082.
20. Ravn-Haren G, Olsen A, Tj ø nneland A, Dragsted LO, Nex ø BA, Wallin H, et al. Associations between GPX1 Pro198Leu polymorphism, erythrocyte GPX activity, alcohol consumption and breast cancer risk in a prospective cohort study. Carcinogenesis 2006; 27: 820-825.
21. Forsberg L, Lyren ä s L, de Faire U, Morgenstern R. A common functional C-T substitution polymorphism in the promoter region of the human catalase gene influences transcription factor binding, reporter gene transcription and is correlated to blood catalase levels. Free Radic Biol Med 2001; 30: 500-505.
22. Ho YS, Crapo JD. Isolation and characterization of complementary DNAs encoding human manganese-containing superoxide dismutase. FEBS Lett 1988; 229: 256-260.
23. Zhang HJ, Yan T, Oberley TD, Oberley LW. Comparison of eff ects of two polymorphic variants of manganese superoxide dismutase on human breast MCF-7 cancer cell phenotype. Cancer Res 1999; 59: 6276-6283.
24. Shimoda-Matsubayashi S, Matsumine H, Kobayashi T, Nakagawa-Hattori Y, Shimizu Y, Mizuno Y. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson' s disease. Biochem Biophys Res Commun 1996; 226: 561-565.
25. Holley AK, Dhar SK, Xu Y, St Clair DK. Manganese superoxide dismutase: beyond life and death. Amino Acids 2012; 42: 139-158.
26. Hiroi S, Harada H, Nishi H, Satoh M, Nagai R, Kimura A. Polymorphisms in the SOD2 and HLA-DRB1 genes are associated with nonfamilial idiopathic dilated cardiomyopathy in Japanese. Biochem Biophys Res Commun 1999; 261: 332-339.
27. Sutton A, Khoury H, Prip-Buus C, Cepanec C, Pessayre D, Degoul F. The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria. Pharmacogenetics 2003; 13: 145-157.
28. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956; 11: 298-300.
29. Goth L. A new type of inherited catalase deficiencies: its characterization and comparison to the Japanese and Swiss type of acatalasemia. Blood Cells Mol Dis 2001; 27: 512-517.
30. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007; 39: 44-84.
31. Cole MP, Chaiswing L, Oberley TD, Edelmann SE, Piascik MT, Lin SM, et al. The protective roles of nitric oxide and superoxide dismutase in adriamycin-induced cardiotoxicity. Cardiovasc Res 2006; 69: 186-197.
32. French JP, Hamilton KL, Quindry JC, Lee Y, Upchurch PA, Powers SK. Exercise-induced protection against myocardial apoptosis and necrosis: MnSOD, calcium-handling proteins, and calpain. FASEB J 2008; 22: 2862-2871.
33. Kanwar M, Chan PS, Kern TS, Kowluru RA. Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase. Invest Ophthalmol Vis Sci 2007; 48: 3805-3811.
34. Goto H, Nishikawa T, Sonoda K, Kondo T, Kukidome D, Fujisawa K, et al. Endothelial MnSOD overexpression prevents retinal VEGF expression in diabetic mice. Biochem Biophys Res Commun 2008; 366: 814-820.
35. Lebovitz RM, Zhang H, Vogel H, Cartwright J Jr, Dionne L, Lu N, et al. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutasedeficient mice. Proc Natl Acad Sci U S A 1996; 93: 9782-9787.
36. Li Y, Huang TT, Carlson EJ, Melov S, Ursell PC, Olson JL, et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 1995; 11: 376-381.
37. Bota DA, Van Remmen H, Davies KJ. Modulation of Lon protease activity and aconitase turnover during aging and oxidative stress. FEBS Lett 2002; 532: 103-106.
38. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res 2010; 107: 1058-1070.
39. Rains JL, Jain SK. Oxidative stress, insulin signaling, and diabetes. Free Radic Biol Med 2011; 50: 567-575.
40. Nakanishi S, Yamane K, Ohishi W, Nakashima R, Yoneda M, Nojima H, et al. Manganese superoxide dismutase Ala16Val polymorphism is associated with the development of type 2 diabetes in Japanese-Americans. Diabetes Res Clin Pract 2008; 81: 381-385.
41. Nomiyama T, Tanaka Y, Piao L, Nagasaka K, Sakai K, Ogihara T, et al. The polymorphism of manganese superoxide dismutase is associated with diabetic nephropathy in Japanese type 2 diabetic patients. J Hum Genet 2003; 48: 138-141.
42. M ö llsten A, Jorsal A, Lajer M, Vionnet N, Tarnow L. The V16A polymorphism in SOD2 is associated with increased risk of diabeticnephropathy and cardiovascular disease in type 1 diabetes. Diabetologia 2009; 52: 2590-2593.
43. M ö llsten A, Marklund SL, Wessman M, Svensson M, Forsblom C, Parkkonen M, et al. A functional polymorphism in the manganese superoxide dismutase gene and diabetic nephropathy. Diabetes 2007; 56: 265-269.
44. Strokov I, Bursa T, Drepa O, Zotova E, Nosikov V, Ametov A. Predisposing genetic factors for diabetic polyneuropathy in patients with type 1 diabetes: a population-based casecontrol study. Acta Diabetol 2003; 40: 375-379.
45. Hovnik T, Dolzan V, Bratina NU, Podkrajsek KT, Battelino T. Genetic polymorphisms in genes encoding antioxidant enzymes are associated with diabetic retinopathy in type 1 diabetes. Diabetes Care 2009; 32: 2258-2262.
46. Kangas-Kontio T, Vavuli S, Kakko SJ, Penna J, Savolainen ER, Savolainen MJ, Liinamaa MJ. Polymorphism of the manganese superoxide dismutase gene but not of vascular endothelial growth factor gene is a risk factor for diabetic retinopathy. Br J Ophthalmol 2009; 93: 1401-1406.
47. Flekac M, Skrha J, Hilgertova J, Lacinova Z, Jarolimkova M. Gene polymorphisms of superoxide dismutases and catalase in diabetes mellitus. BMC Med Genet 2008; 9: 30.
48. Chen H, Yu M, Li M, Zhao R, Zhu Q, Zhou W, et al. Polymorphic variations in manganese superoxide dismutase (MnSOD), glutathione peroxidase-1 (GPX1), and catalase (CAT) contribute to elevated plasma triglyceride levels in Chinese patients with type 2 diabetes or diabetic cardiovascular disease. Mol Cell Biochem 2012; 363: 85-91.
49. Zalba G, San Jose G, Moreno MU, Fortuno MA, Fortuno A, Beaumont FJ, D í ez J. Oxidative stress in arterial hypertension: role of NAD(P)H oxidase. Hypertension 2001; 38: 1395-1399.
50. Gongora MC, Qin Z, Laude K, Kim HW, McCann L, Folz JR, et al. Role of extracellular superoxide dismutase in hypertension. Hypertension 2006; 48: 473-481.
51. Song WZ, Chen AF, Wang DH. Increased salt sensitivity induced by sensory denervation: role of superoxide. Acta Pharmacol Sin 2004; 25: 1626-1632.
52. Kardia SL, Greene MT, Boerwinkle E, Turner ST, Kullo IJ. Investigating the complex genetic architecture of anklebrachial index, a measure of peripheral arterial disease, in non-Hispanic whites. BMC Med Genomics 2008; 1: 16.
53. Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006; 86: 515-581.
54. Ballinger SW, Patterson C, Knight-Lozano CA, Burow DL, Conklin CA, Hu, Z, et al. Mitochondrial integrity and function in atherogenesis. Circulation 2002; 106: 544-549.
55. Dikalova AE, Bikineyeva AT, Budzyn K, Nazarewicz RR, McCann L, Lewis W, et al. Therapeutic targeting of mitochondrial superoxide in hypertension. Circ Res 2010; 107: 106-116.
56. Kakko S, Paivansalo M, Koistinen P, Kesaniemi YA, Kinnula VL, Savolainen MJ. The signal sequence polymorphism of the MnSOD gene is associated with the degree of carotid atherosclerosis. Atherosclerosis 2003; 168: 147-152.
57. Hsueh YM, Lin P, Chen HW, Shiue HS, Chung CJ, Tsai CT, et al. Genetic polymorphisms of oxidative and antioxidant enzymes and arsenic-related hypertension. J Toxicol Environ Health A 2005; 68: 1471-1484.
58. Valenti L, Conte D, Piperno A, Dongiovanni P, Francanzani AL, Vergani A, et al. The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis. J Med Genet 2004; 41: 946-950.
59. Gottlieb MG, Schwanke CH, Santos AF, Jobim PF, M ü ssel DP, da Cruz IB. Association among oxidized LDL levels, MnSOD, apolipoprotein E polymorphisms, and cardiovascular risk factors in a south Brazilian region population. Genet Mol Res 2005; 4: 691-703.
60. Fujimoto H, Taguchi J, Imai Y, Ayabe S, Hashimoto H, Kobayashi H, et al. Manganese superoxide dismutase polymorphism aff ects the oxidized low-density lipoproteininduced apoptosis of macrophages and coronary artery disease. Eur Heart J 2008; 29: 1267-1274.
61. Fujimoto H, Kobayashi H, Ogasawara K, Yamakado M, Ohno M. Association of the manganese superoxide dismutase polymorphism with vasospastic angina pectoris. J Cardiol 2010; 55: 205-210.
62. Charniot JC, Sutton A, Bonnefont-Rousselot D, Cosson C, Khani-Bittar R, Giral P, et al. Manganese superoxide dismutase dimorphism relationship with severity and prognosis in cardiogenic shock due to dilated cardiomyopathy. Free Radic Res 2011; 45: 379-388.
63. Kukiełka E, Cederbaum AI. NADH-dependent microsomal interaction with ferric complexes and production of reactive oxygen intermediates. Arch Biochem Biophys 1989; 275: 540-550.
64. Kukiełka E, Dicker E, Cederbaum AI. Increased production of reactive oxygen species by rat liver mitochondria after chronic ethanol treatment. Arch Biochem Biophys 1994; 309: 377-386.
65. Parola M, Robino G. Oxidative stress-related molecules and liver fibrosis. J Hepatol 2001; 35: 297-306.
66. Bomford A. Genetics of haemochromatosis. Lancet 2002; 360: 1673-1681.
67. Mansouri A, Gaou I, De Kerguenec C, Amsellem S, Haouzi D, Berson A, et al. An alcoholic binge causes massive degradation of hepatic mitochondrial DNA in mice. Gastroenterology 1999; 117: 181-190.
68. Mauriz JL, Gonzalez P, Jorquera F, Olcoz JL, Gonzalez- Gallego J. Caspase inhibition does not protect against liver damage in hemorrhagic shock. Shock 2003; 19: 33-37.
69. El-Koofy NM, El-Karaksy HM, Mandour IM, Anwar GM, El-Raziky MS, El-Hennawy AM. Genetic polymorphisms in non-alcoholic fatty liver disease in obese Egyptian children. Saudi J Gastroenterol 2011; 17: 265-270.
70. Stewart SF, Leathart JB, Chen Y, Daly AK, Rolla R, Vay D, et al. Valine-alanine manganese superoxide dismutase polymorphism is not associated with alcohol-induced oxidative stress or liver fibrosis. Hepatology 2002; 36: 1355-1360.
71. Martins A, Cortez-Pinto H, Machado M, Gon ç alves MS, Soren S, Marques-Vidal P, et al. Are genetic polymorphisms of tumour necrosis factor alpha, interleukin-10, CD14 endotoxin receptor or manganese superoxide dismutase associated with alcoholic liver disease? Eur J Gastroenterol Hepatol 2005; 17: 1099-1104.
72. Stickel F, Osterreicher CH, Datz C, Ferenci P, W ö lfel M, Norgauer W, et al. Prediction of progression to cirrhosis by a glutathione S-transferase P1 polymorphism in subjects with hereditary hemochromatosis. Arch Intern Med 2005; 165: 1835-1840.
73. Sutton A, Nahon P, Pessayre D, Rufat P, Poir é A, Ziol M, et al. Genetic polymorphisms in antioxidant enzymes modulate hepatic iron accumulation and hepatocellular carcinoma development in patients with alcohol-induced cirrhosis. Cancer Res 2006; 66: 2844-2852.
74. Nahon P, Sutton A, Rufat P, Ziol M, Akouche H, Laguillier C, et al. Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis. Hepatology 2009; 50: 1484-1493.
75. Nahon P, Sutton A, Rufat P, Charnaux N, Mansouri A, Moreau R, et al. A variant in myeloperoxidase promoter hastens the emergence of hepatocellular carcinoma in patients with HCV-related cirrhosis. J Hepatol 2012; 56: 426-432.
76. Namikawa C, Shu-Ping Z, Vyselaar JR, Nozaki Y, Nemoto Y, Ono M, et al. Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis. J Hepatol 2004; 40: 781-786.
77. Montano MA, Barrio Lera JP, Gottlieb MG, Schwanke CH, da Rocha MI, Manica-Cattani MF, et al. Association between manganese superoxide dismutase (MnSOD) gene polymorphism and elderly obesity. Mol Cell Biochem 2009; 328: 33-40.
78. Duarte MM, Moresco RN, Duarte T, Santi A, Bagatini MD, Da Cruz IB, et al. Oxidative stress in hypercholesterolemia and its association with Ala16Val superoxide dismutase gene polymorphism. Clin Biochem 2010; 43: 1118-1123.
79. dos Santos Montagner GF, Sagrillo M, Machado MM, Almeida RC, Mostardeiro CP, Duarte MM, da Cruz IB. Toxicological eff ects of ultraviolet radiation on lymphocyte cells with diff erent manganese superoxide dismutase Ala16Val polymorphism genotypes. Toxicol In Vitro 2010; 24: 1410-1416.
80. Kowalski M, Bielecka-Kowalska A, Oszajca K, Eusebio M, Jaworski P, Bartkowiak J, Szemraj J. Manganese superoxide dismutase (MnSOD) gene (Ala-9Val, Ile58Thr) polymorphism in patients with age-related macular degeneration (AMD). Med Sci Monit 2010; 16: CR190-CR196.
81. Isbir S, Ergen A, Yilmaz H, Tekeli A, Arsan S. Eff ect of Ala16Val genetic polymorphism of MnSOD on antioxidant capacity and inflammatory response in open heart surgery. In Vivo 2008; 22: 147-151.
82. Montano MA, da Cruz IB, Duarte MM, Krewer Cda C, da Rocha MI, M â nica-Cattani MF, et al. Inflammatory cytokines in vitro production are associated with Ala16Val superoxide dismutase gene polymorphism of peripheral blood mononuclear cells. Cytokine 2012; 60: 30-33.
83. Bica CG, da Silva LL, Toscani NV, Zettler CG, Gottlieb MG, Alexandre CO, et al. Polymorphism (ALA16VAL) correlates with regional lymph node status in breast cancer. Cancer Genet Cytogenet 2010; 196: 153-158.
84. Bica CG, de Moura da Silva LL, Toscani NV, da Cruz IB, Sá G, Graudenz MS, Zettler CG. MnSOD gene polymorphism association with steroid-dependent cancer. Pathol Oncol Res 2009; 15: 19-24.
85. Kucukgergin C, Sanli O, Amasyali AS, Tefik T, Seckin S. Genetic variants of MnSOD and GPX1 and susceptibility to bladder cancer in a Turkish population. Med Oncol 2012; 29: 1928-1934.
86. Zejnilovic J, Akev N, Yilmaz H, Isbir T. Association between manganese superoxide dismutase polymorphism and risk of lung cancer. Cancer Genet Cytogenet 2009; 189: 1-4.
87. Wheatley-Price P, Asomaning K, Reid A, Zhai R, Su L, Zhou W, et al. Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma. Cancer 2008; 112: 1037-1042.
88. Liu G, Zhou W, Park S, Wang LI, Miller DP, Wain JC, et al. The SOD2 Val/Val genotype enhances the risk of nonsmall cell lung carcinoma by p53and XRCC1 polymorphisms. Cancer 2004; 101: 2802-2808.
89. Koistinen P, Ruuska S, Saily M, Kakko S, Siitonen P, Siitonen T, et al. An association between manganese superoxide dismutase polymorphism andoutcome of chemotherapy in acute myeloid leukemia. Haematologica 2006; 91: 829-832.
90. Nahon P, Charnaux N, Friand V, Prost-Squarcioni C, Ziol M, Li è vre N, et al. The manganese superoxide dismutase Ala16Val dimorphism modulates iron accumulation in human hepatoma cells. Free Radic Biol Med 2008; 45: 1308-1317.
91. Slanger TE, Chang-Claude J, Wang-Gohrke S. Manganese superoxide dismutase Ala-9Val polymorphism, environmental modifiers, and risk of breast cancer in a German population. Cancer Causes Control 2006; 17: 1025-1031.
92. Kang D, Lee KM, Park SK, Berndt SI, Peters U, Reding D, et al. Functional variant of manganese superoxide dismutase (SOD2 V16A) polymorphism is associated with prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer study. Cancer Epidemiol Biomarkers Prev 2007; 16: 1581-1586.
93. Ambrosone C, Fredenheim J, Thompson P, Bowman E, Vena J, Marshall J, et al. Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Res 1999; 59: 602-606.
94. Mikhak B, Hunter DJ, Spiegelman D, Platz EA, Wu K, Erdman JW Jr, Giovannucci E. Manganese superoxide dismutase (MnSOD) gene polymorphism, interactions with carotenoid levels and prostate cancer risk. Carcinogenesis 2008; 29: 2335-2340.
95. Tong SY, Lee JM, Song ES, Lee KB, Kim MK, Lee JK, et al. Functional polymorphism in manganese superoxide dismutase and antioxidant status: their interactions on the risk of cervical intraepithelial neoplasia and cervical cancer. Gynecol Oncol 2009; 115: 272-276.
96. Choi JY, Neuhouser ML, Barnett M, Hudson M, Kristal AR, Thornquist M, et al. Polymorphisms in oxidative stressrelated genes are not associated with prostate cancer risk in heavy smokers. Cancer Epidemiol Biomarkers Prev 2007; 16: 1115-1120.
97. Caple F, Williams EA, Spiers A, Tyson J, Burtle B, Daly AK, et al. Inter-individual variation in DNA damage and base excision repair in young, healthy non-smokers: eff ects of dietary supplementation and genotype. Br J Nutr 2010; 103: 1585-1593.
98. Nikolaidis MG, Kyparos A, Spanou C, Paschalis V, Theodorou AA, Vrabas IS. Redox biology of exercise: an integrative and comparative consideration of some overlooked issues. J Exp Biol 2012; 215: 1615-1625.
99. Radak Z, Chung HY, Koltai E, Taylor AW, Goto S. Exercise, oxidative stress and hormesis. Ageing Res Rev 2008; 7: 34-42.
100. Cuevas MJ, Almar M, Garc í a-Glez JC, Garc í a-L ó pez D, De Paz JA, Alvear-Ordenes I, Gonz á lez-Gallego J. Changes in oxidative stress markers and NF-kappaB activation induced by sprint exercise. Free Radic Res 2005; 39: 431-439.
101. Veneroso C, Tu ñ ó n MJ, Gonz á lez-Gallego J, Collado PS. Melatonin reduces cardiac inflammatory injury induced by acute exercise. J Pineal Res 2009; 47: 184-191.
102. Akimoto AK, Miranda-Vilela AL, Alves PC, Pereira LC, Lordelo GS, Hiragi Cde O, et al. Evaluation of gene polymorphisms in exercise-induced oxidative stress and damage. Free Radic Res 2010; 44: 322-331.
103. Bresciani G, Gonz á lez-Gallego J, da Cruz IB, de Paz JA, Cuevas MJ. The Ala16Val MnSOD gene polymorphism modulates oxidative response to exercise. Clin Biochem 2013; 46: 335-340.
104. Miranda-Vilela AL, Akimoto AK, Alves PC, Pereira LC, Gon ç alves CA, Klautau-Guimar ã es MN, Grisolia CK. Dietary carotenoid-rich pequi oil reduces plasma lipid peroxidation and DNA damage in runners and evidence for an association with MnSOD genetic variant -Val9Ala. Genet Mol Res 2009; 8: 1481-1495.
105. Young-McCaughan S. Potential for prostate cancer prevention through physical activity. World J Urol 2012; 30: 167-179.
106. Fernandes T, Nakamuta JS, Magalh ã es FC, Roque FR, Lavini-Ramos C, Schettert IT, et al. Exercise training restores the endothelial progenitor cells number and function in hypertension: implications for angiogenesis. J Hypertens 2012; 30: 2133-2143.
107. Oliveira C, Sim õ es M, Carvalho J, Ribeiro J. Combined exercise for people with type 2 diabetes mellitus: a systematic review. Diabetes Res Clin Pract 2012; 98: 187-198.
108. Ookawara T, Haga S, Ha S, Oh-Ishi S, Toshina K, Kizaki T, et al. Eff ects of endurance training on three superoxide dismutase isoenzymes in human plasma. Free Radic Res 2003; 37: 713-719.
109. Xu X, Zhao W, Wan W, Ji LL, Powers AS, Erikson JM, Zhang JQ. Exercise training combined with angiotensin II receptor blockade reduces oxidative stress after myocardial infarction in rats. Exp Physiol 2010; 95: 1008-1015.
110. Garc í a-L ó pez D, H ä kkinen K, Cuevas MJ, Lima E, Kauhanen A, Mattila M, et al. Eff ects of strength and endurance training on antioxidant enzyme gene expression and activity in middle-aged men. Scand J Med Sci Sports 2007; 17: 595-604.
111. Miranda-Vilela AL, Alves PC, Akimoto AK, Pereira LC, Nazar é Klautau-Guimar ã es Md, Grisolia CK. The eff ect of hydrogen peroxide-induced oxidative stress on leukocytes depends on age and physical training in healthy human subjects carrying the same genotypes of antioxidant enzymes' gene polymorphisms. Am J Hum Biol 2010; 22: 807-812.
112. Dhar SK, St Clair DK. Manganese superoxide dismutase regulation and cancer. Free Radic Biol Med 2012; 52: 2209-2222.